Promethera Biosciences Competitors and Similar CompaniesClear all
Promethera Biosciences's competitors and similar companies include Poxel, Gilead Sciences, Allergan and Pfizer.
 Promethera Biosciences Promethera Biosciences is a healthcare company developing cell therapy technologies for chronic liver diseases. |  Poxel Poxelis a research integrated pharmaceutical company that develops products for metabolic diseases. |  Gilead Sciences Gilead Sciences is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of medicines. |  Allergan Allergan is a healthcare company focused on developing, manufacturing, and commercializing branded pharmaceutical, device, biologic, surgical, and regenerative medicine products. |  Pfizer Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products. | |
Founding Date | Founding Date 2009 | Founding Date 2009 | Founding Date 1987 | Founding Date 1948 | Founding Date 1849 |
Type | Type Subsidiary | Type Public | Type Public | Type Subsidiary | Type Public |
Tags | |||||
Locations | Locations Mont-Saint-Guibert, BE HQ Charleroi, BE Ganshoren, BE Chuo City, JP Chuo City, JP Basel, CH Durham, US see more | Locations Lyon, FR HQ Chiyoda City, JP Cambridge, US | Locations Foster City, US HQ Buenos Aires, AR Melbourne, AU Wien, AT Machelen, BE São Paulo, BR Edmonton, CA see more | Locations Dublin, IE HQ Buenos Aires, AR Roseville, AU Machelen, BE Guarulhos, BR Las Condes, CL Bogotá, CO see more | Locations New York, US HQ Buenos Aires, AR Villa Adelina, AR Footscray, AU Mulgrave, AU Sydney, AU Wien, AT see more |
Employees | Employees 185% decrease | Employees 6 | Employees 18,0006% increase | Employees 10,5471% decrease | Employees 81,0008% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 18.3 m | Valuation ($) 110.5 b | Valuation ($) N/A | Valuation ($) 163.9 b |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) €6.6m (FY, 2024) | Revenue (est.) $29.4b (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $62.6b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods €2.8m (FY, 2024) | Cost of goods $6.2b (FY, 2025) | Cost of goods N/A | Cost of goods $16.1b (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit €3.8m (FY, 2024) | Gross profit $23.2b (FY, 2025) | Gross profit N/A | Gross profit $46.5b (FY, 2025) |
Net income | Net income N/A | Net income (€18.3m) (FY, 2024) | Net income $8.5b (FY, 2025) | Net income N/A | Net income $7.8b (FY, 2025) |
Operating ⚠ | |||||
Countries | Countries N/A | Countries N/A | Countries 35 (FY, 2021) | Countries 100 (Q1, 2020) | Countries 200 (FY, 2024) |
Phase III Trials Products | Phase III Trials Products N/A | Phase III Trials Products N/A | Phase III Trials Products 9 (FY, 2021) | Phase III Trials Products N/A | Phase III Trials Products 32 (FY, 2024) |
Funding | |||||
Total funding raised | Total funding raised $ 146m | Total funding raised $ 33.8m | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Poxel
HQ
Lyon, FR
Employees
6
Poxelis a research integrated pharmaceutical company that develops products for metabolic diseases.
View companyGilead Sciences
HQ
Foster City, US
Employees
18,000↑ 6% increase
Gilead Sciences is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of medicines.
View companyAllergan
HQ
Dublin, IE
Allergan is a healthcare company focused on developing, manufacturing, and commercializing branded pharmaceutical, device, biologic, surgical, and regenerative medicine products.
View companyPfizer
HQ
New York, US
Employees
81,000↓ 8% decrease
Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products.
View company